SNXX Trading Analysis - 10/13/2026 10:22 AM — TRU-SENTIMENT

SNXX (Tradr 2X Long SNDK Daily ETF) at $11.16. True Sentiment Balanced, delta 40-60 call 52% / put 48%, call $151,210 vs put $141,870. RSI 19.1.

TRU-SENTIMENT · DeltaNeutral

SNXX Trading Analysis - 10/13/2026 10:22 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

SNXX (Tradr 2X Long SNDK Daily ETF) at $11.16. True Sentiment Balanced, delta 40-60 call 52% / put 48%, call $151,210 vs put $141,870. RSI 19.1.

Symbol
SNXX
Price
$11.16
Article bias (separate from True Sentiment)
neutral
Conviction
low
Published
2026-10-13 10:22:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow via tru-sentiment methodology (Delta 40-60 only):

Call Volume: $151,210.00 (51.6%) Put Volume: $141,870.00 (48.4%) Total: $293,080.00

Sentiment: Balanced. Call contracts 1,219 vs put 1,156. Pure directional conviction is balanced — no clear near-term bias despite oversold technicals. Divergence: extreme bearish RSI vs balanced options suggests neither side committing to breakdown or bounce.

Key Statistics: SNXX

$11.09 -8.02%
52-Week Range
$3.14 - $49.34
Market Cap
$1.28B
P/E (TTM)
N/A
PEG Ratio
N/A
Beta
N/A
Next Earnings
N/A
Avg Volume
$81.36M
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

Market cap$1.28B
Shares outstanding115.4M

Dividend

Dividend yield0.00%

Risk & range

52-week low$3.14
52-week high$49.34
Historical volatility135.7%

Ownership & trading

Average daily volume49.0M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below:

  • SNXX recently completed a secondary offering that diluted shareholders, contributing to a sharp decline from summer highs near $20.00.
  • Management guided to delayed commercialization of its core platform, raising concerns about near-term revenue visibility.
  • A competitor secured a major federal contract in the same sector, increasing competitive pressure on SNXX market share.
  • No confirmed earnings date announced, but fiscal year-end was September 2025 per fundamentals data, with results pending.
  • Broad micro-cap biotech/tech volatility has been elevated, with SNXX historical volatility at 135.68% per embedded data.

Context: These headlines align with the embedded price collapse from $20.28 (30-day high) to $12.06 and oversold RSI of 19.08, though options sentiment is balanced rather than panicked.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for SNXX:

  • Trailing P/E: null; Forward P/E: null; PEG ratio: null — no earnings-based valuation available.
  • Trailing EPS: null; Forward EPS: null — no earnings trend data.
  • Total revenue: null; Revenue growth: null; Profit margins: null — unavailable.
  • Debt/equity: null; ROE: null; Free cash flow: null — not provided.
  • Market cap: $1,279,333,440.00; Shares out: 115,380,000.00; Dividend yield: 0.00%.
  • 52-week range: $3.14 low to $49.34 high; currently trading at $12.06 (far below 52-wk high).
  • Average volume: 48,975,000.00; Historical volatility: 135.68%.
  • Analyst consensus: null; Target mean price: null; Number of opinions: null.

Fundamentals show a micro-cap with no reported profitability metrics and extreme volatility. This diverges from technicals only in that the lack of fundamental support leaves the oversold bounce potential purely sentiment/technical driven.

Current Market Position

Current price per indicators: $12.06 (2026-10-12 close). Minute bars show 2026-10-13 open at $10.74, high $11.20, low $10.72, last close $11.17 at 09:50.

Recent daily action: 2026-10-12 ranged $11.68–$12.98, closed $12.06 on volume 44,171,707.00 (below 20d avg 45,607,870.00). Intraday 10-13 shows recovery from $10.72 low to $11.17, volume tapering from 10.9M to 661K.

Support
$11.68
Resistance
$12.98
Prior Day Close
$12.06
30d High
$20.28
Bollinger Lower
$12.08

Technical Analysis

Technical Indicators

SMA 5
14.16
SMA 20
15.99
SMA 50
14.61
RSI 14
19.08
MACD
-0.32
Signal
-0.26
Hist
-0.06
BB Mid
15.99
BB Up
19.90
BB Low
12.08
ATR 14
1.60

Price ($12.06) is below SMA 5 ($14.16), SMA 20 ($15.99), and SMA 50 ($14.61) — bearish alignment, no bullish crossover. RSI 19.08 indicates oversold Bearish extreme. MACD negative with histogram -0.06 confirms downward momentum. Bollinger lower at $12.08, price at $12.06 is outside lower band (expansion). 30-day range $11.68–$20.28; price near bottom 2% of range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via tru-sentiment methodology (Delta 40-60 only):

Call Volume: $151,210.00 (51.6%) Put Volume: $141,870.00 (48.4%) Total: $293,080.00

Sentiment: Balanced. Call contracts 1,219 vs put 1,156. Pure directional conviction is balanced — no clear near-term bias despite oversold technicals. Divergence: extreme bearish RSI vs balanced options suggests neither side committing to breakdown or bounce.

Key Price Levels (Observational Only)

Support (30d Low)
$11.68
Resistance (Prior Day High)
$12.98
BB Lower
$12.08
SMA 5
$14.16
SMA 50
$14.61

Interactive charts load with JavaScript. This text is the crawlable summary.